Na Xu

FAIRLANE, a double-blind placebo-controlled randomized phase II trial of neoadjuvant ipatasertib plus paclitaxel for early triple-negative breast cancer

Mafalda Oliveira, Cristina Saura, Paolo Nucíforo et al. · Annals of Oncology · 2019 · 153 citations · Full text

Medicine, Oncology, Pharmacology +13

Final results of the double-blind placebo-controlled randomized phase 2 LOTUS trial of first-line ipatasertib plus paclitaxel for inoperable locally advanced/metastatic triple-negative breast cancer

Rebecca Dent, Mafalda Oliveira, Steven J. Isakoff et al. · Breast Cancer Research and Treatment · 2021 · 74 citations

Medicine, Oncology, Pharmacology +14

Association of ABO Blood Groups and Risk of Gastric Cancer

Hao Yu, Na Xu, Zhongkun Li et al. · Scandinavian Journal of Surgery · 2019 · 42 citations

Medicine, Hematology, Oncology +12

Effect of laparoscopic gastrectomy on compliance with adjuvant chemotherapy in patients with gastric cancer

Huizheng Bao, Na Xu, Zhongkun Li et al. · Medicine · 2017 · 14 citations · Full text

Medicine, Oncology, Surgery +16

Olverembatinib (HQP1351) Demonstrates Efficacy Vs. Best Available Therapy (BAT) in Patients (Pts) with Tyrosine Kinase Inhibitor (TKI)-Resistant Chronic Myeloid Leukemia Chronic-Phase (CML-CP) in a Registrational Randomized Phase 2 Study

Zongru Li, Yu Hu, Wei‐Ming Li et al. · Blood · 2023 · 11 citations

Medicine, Oncology, Pharmacology +11